<PAGE>
OMB APPROVAL
OMB Number:3235-0145
Expires:December 31, 1997
Estimated average burden
hours per form 14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. *)
Integramed America, Inc.
(Name of Issuer)
Common Stock
- -------------------------------------------------------------------
(Title of Class of Securities)
45810N10
(CUSIP Number)
Eric M. Sippel, Esq.
c/o SHARTSIS, FRIESE & GINSBURG LLP
One Maritime Plaza, 18th Floor
San Francisco, California 94111
(415) 421-6500
- ------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
August 15, 1997
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this Schedule
13D, and is filing this schedule because of Rule 13d-1(b)(3) or
(4), check the following box / /.
Check the following box if a fee is being paid with the statement
/ /. (A fee is not required only if the reporting person: (1)
has a previous statement on file reporting beneficial ownership of
more than five percent of the class of securities described in Item
1; and (2) has filed no amendment subsequent thereto reporting
beneficial ownership of five percent or less of such class.) (See
Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should
be filed with the Commission. See Rule 13d-1(a) for other parties
to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a
prior cover page.
The information required on the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
SEC 1746 (12-91)
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 2 of 10 Pages
- ------------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON
London Merchant Securities plc
- ------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /*/
(b) / /
- ------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- ------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) / /
- ------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
- ------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES -0-
BENEFICIALLY -----------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 850,000
REPORTING -----------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH -0-
-----------------------------------------
10 SHARED DISPOSITIVE POWER
850,000
- ------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
850,000
- ------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* / /
- ------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.9%
- ------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
00
- ------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE,
AND THE SIGNATURE ATTESTATION.
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 3 of 10 Pages
- ----------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON
Lion Investments Limited
- ----------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /*/
(b) / /
- ----------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- ----------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) / /
- ----------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
- ----------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 850,000
BENEFICIALLY ---------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH -0-
REPORTING ---------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 850,000
---------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- ----------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
850,000
- ----------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* / /
- ----------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.9%
- ----------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
- ----------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE,
AND THE SIGNATURE ATTESTATION.
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 4 of 10 Pages
- ----------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON
Eugene M. Weber
- ----------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)/*/
(b)/ /
- ----------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- ----------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) / /
- ----------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ----------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 10,000
BENEFICIALLY ---------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH -0-
REPORTING ---------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 10,000
---------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- ----------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,000
- ----------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* / /
- ----------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.05%
- ----------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- ----------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE,
AND THE SIGNATURE ATTESTATION.
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 5 of 10 Pages
- ----------------------------------------------------------------
1 NAME OF REPORTING PERSON
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON
Morris Cheston III
- ----------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) /*/
(b) / /
- ----------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- ----------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) / /
- ----------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ----------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 5,000
BENEFICIALLY ---------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH -0-
REPORTING ---------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 5,000
---------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- ----------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,000
- ----------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* / /
- ----------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.03%
- ----------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- ----------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE,
AND THE SIGNATURE ATTESTATION.
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 6 of 10 Pages
ITEM 1. SECURITY AND ISSUER.
This statement relates to shares of common stock (the "Securities")
of Integramed America, Inc. ("INMD"). The principal executive
office of INMD is located at One Manhattanville Road, Purchase, NY
10577.
ITEM 2. IDENTITY AND BACKGROUND.
The persons filing this statement and the persons enumerated in
Instruction C of Schedule 13D and, where applicable, their
respective places of organization, general partners, directors,
executive officers and controlling persons, and the information
regarding them, are as follows:
(a) London Merchant Securities plc ("LMS"); Lion Investments
Limited ("Lion"); Eugene M. Weber ("Weber"); and Morris Cheston III
("Cheston").
(b) The business address of LMS and Lion is 33 Robert Adam Street,
London WIM 5AH, United Kingdom. The business address of Weber and
Cheston is 50 California Street, Suite 3200, San Francisco, CA
94111.
(c) Weber is the president and sole shareholder of Bluewater
Capital Management, Inc., a California corporation ("Bluewater,
Inc."), and the managing member of Bluewater Investments LLC, a
California limited liability company ("Bluewater LLC"). Cheston is
an employee of Bluewater, Inc.
(d) During the last five years, none of such persons has been
convicted in a criminal proceeding (excluding traffic violations or
similar misdemeanors).
(e) During the last five years, none of such persons was a party
to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with
respect to such laws.
(f) LMS and Lion are limited companies organized under the laws of
England and Wales. Weber and Cheston are citizens of the United
States.
<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 7 of 10 Pages
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
The source and amount of funds used in purchasing the Securities
were as follows:
Purchaser Source of Funds Amount
LMS Working Capital* $1,171,875.00
Lion Working Capital $1,171,875.00
Weber Personal Funds $ 15,000.00
Cheston Personal Funds $ 7,500.00
* Includes funds of Lion invested in Securities.
ITEM 4. PURPOSE OF TRANSACTION.
The principal purpose of the acquisitions of securities is
investment. The persons named in Item 2 of this statement have no
plans or proposals that relate to or would result in:
(a) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving INMD or any of its
subsidiaries;
(b) A sale or transfer of a material amount of assets of INMD or
of any of its subsidiaries;
(c) Any change in the present board of directors or management of
INMD, including any plans or proposals to change the number or term
of directors or to fill any existing vacancies on the board;
(d) Any material change in the present capitalization or dividend
policy of INMD;
(e) Any other material change in INMD's business or corporate
structure;
(f) Changes in INMD's charter, bylaws or instruments corresponding
thereto or other actions which may impede the acquisition of
control of INMD by any person;
(g) Causing a class of securities of INMD to be delisted from a
national securities exchange or to cease to be authorized to be
quoted in an inter-dealer quotation system of a registered national
securities association;
(h) A class of equity securities of INMD becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the
Securities Exchange Act of 1934, as amended; or
(i) Any action similar to any of those enumerated above.<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 8 of 10 Pages
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
The beneficial ownership of the Securities of the persons named in
Item 2 of this statement is as follows at the date hereof:
Aggregate
Beneficially
Owned Voting Power Dispositive Power
Name Number Percent Sole Shared Sole Shared
LMS 850,000 4.9% -0- 850,000 -0- 850,000
Lion 850,000 4.9% -0- 850,000 -0- 850,000
Weber 10,000 0.05% 10,000 -0- 10,000 -0-
Cheston 5,000 0.03% 5,000 -0- 5,000 -0-
The persons filing this statement effected the following
transactions in the Securities on the dates indicated, and such
transactions are the only transactions in the Securities since June
16, 1997, by the persons filing this statement:
Purchase Number Price
Name or Sale Date of Shares Per Share
Lion P 8/15 1,000,000 $1.50
Weber P 8/15 10,000 $1.50
Cheston P 8/15 5,000 $1.50
Lion S 8/25 150,000 $2.1875
All transactions were executed through Nasdaq.<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 9 of 10 Pages
ITEM. 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS
WITH RESPECT TO SECURITIES OF THE ISSUER.
Lion is a wholly owned subsidiary of LMS, which is publicly listed
in the United Kingdom. Pursuant to its consultancy agreement (the
"Agreement") with Lion, Bluewater LLC provides investment advice to
Lion. Under the Agreement, Bluewater LLC has no authority to
invest Lion's funds or to vote or dispose of securities purchased
with such funds. The Agreement may be terminated by either party
on notice as provided in the Agreement and provides for Lion to pay
to Bluewater LLC monthly consulting fees and, if certain conditions
are met, additional fees based on realized and unrealized gains and
losses attributed to Bluewater LLC's investment advice to Lion.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
A. Agreement Regarding Joint Filing of Statement on Schedule 13D
or 13G (previously filed).
SIGNATURES
After reasonable inquiry and to the best of my knowledge, I
certify that the information set forth in this statement is true,
complete and correct.
DATED: August 19, 1997
London Merchant Securities plc
By: /s/ Robert A. Rayne
Robert A. Rayne
Director
Lion Investments Limited
By: /s/ Robert A. Rayne
Robert A. Rayne
Director
/s/Eugene M. Weber
Eugene M. Weber
/s/ Morris Cheston III
Morris Cheston III<PAGE>
<PAGE>
SCHEDULE 13D
CUSIP No. 45810N10 Page 10 of 10 Pages
EXHIBIT A
AGREEMENT REGARDING JOINT FILING
OF STATEMENT ON SCHEDULE 13D OR 13G
The undersigned agree to file jointly with the Securities and
Exchange Commission (the "SEC") any and all statements on Schedule
13D or Schedule 13G (and any amendments or supplements thereto)
required under section 13(d) of the Securities Exchange Act of
1934, as amended, in connection with purchases by the undersigned
of common stock of Integramed America, Inc. For that purpose, the
undersigned hereby constitute and appoint London Merchant
Securities plc, a limited company organized under the laws of
England and Wales, as their true and lawful agent and attorney-in-
fact, with full power and authority for and on behalf of the
undersigned to prepare or cause to be prepared, sign, file with the
SEC and furnish to any other person all certificates, instruments,
agreements and documents necessary to comply with section 13(d) and
section 16(a) of the Securities Exchange Act of 1934, as amended,
in connection with said purchases, and to do and perform every act
necessary and proper to be done incident to the exercise of the
foregoing power, as fully as the undersigned might or could do if
personally present.
DATED: August 19, 1997
London Merchant Securities plc
By: /s/ Robert A. Rayne
Robert A. Rayne
Director
Lion Investments Limited
By: /s/ Robert A. Rayne
Robert A. Rayne
Director
/s/Eugene M. Weber
Eugene M. Weber
/s/ Morris Cheston III
Morris Cheston III
C:\DMS\5054\003\0225564.01
